Global Biotechnology Industry
NEW YORK, April 24, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0788386/Global-Biotechnology-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biotechno
The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird's eye view of the Biotechnology industry. Annotated with 21 fact, and data rich tables the report offers a sneak peek into major end-use industries. Also included is a compilation of all recent mergers, acquisitions, and strategic corporate developments. A regional-level of discussion mirrors the prevalent scenario in key regional markets such as the US, Canada, Mexico, Japan, France, Germany, Poland, UK, Sweden, Switzerland, New Zealand, India, Malaysia, and Brazil, among few others. The report also includes an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 1,180 companies worldwide.
1. BIOTECHNOLOGY 1
Global Market Overview 1
Global Biotechnology Industry Recovers Strongly from Recession 1
Current and Future Analysis 2
Table 1: Global Biotechnology Market by Geographic Region -
US, Europe, Asia- Pacific and Rest of World with Annual
Revenues in US$ million for Years 2010 through 2015 3
Table 2: Global Biotechnology Market (2011&2015) Percentage
Breakdown of Value Sales by Geographic Region - US, Europe,
Asia-Pacific and Rest of World 4
Table 3: Global Biotechnology Market by Product Application -
Medical (Therapeutics, Diagnostics and Other Medical Biotech
Applications), Biotech Services and Other Biotech
Applications with Annual Revenues in US$ million for Years
2010 through 2015 5
Table 4: Global Biotechnology Market (2011 & 2015):
Percentage Breakdown of Value Sales by Product Application -
Medical (Therapeutics, Diagnostics and Other Medical Biotech
Applications), Biotech Services and Other Biotech
Applications 6
Table 5: Global Biotechnology Industry (2010): Percentage
Breakdown by Funding Type - Public Offering, Venture Funding
& Others 6
Table 6: Leading Countries in Terms of Mergers and
Acquisitions in the Biotech Space (2010) 7
Market for "Follow-On" Biologics 7
Marine Biotechnology 7
Major Trends 8
Developing Countries to Emerge as Major Biotech Hubs 8
Application of Biotechnology Techniques to Rise Tremendously 8
Biotech Acquisitions Get More Focused 8
Major M&A Activities 8
Contract Manufacturing - A New Business Motto for
Biotechnology Companies 9
Oncology Dominates Biotech Drugs Sale 9
Investment on Research: Vital for the Survival of Biotech
Companies 9
Asia-Pacific: A Promising Market for Biopharmaceutical Companies 9
Biotech Regenerative Medicine Catching On 10
Reverse Merger Transactions Characterizes the Asian Biotech
Sector 10
Biotech Instrumentation to Speed Up Biotech Research Process 10
Growth of Bioventure Startups in Japan 10
Advent of "Mid-Tier" Companies in the Biotech Market 10
Biogenerics Poised for a Big Entry 10
Development of DNA Vaccines 11
Issues Related to Pricing and Reimbursement of Biotech Drugs 11
End-Use Industries 11
Overview of Agricultural and Food Biotechnology 11
Table 7: Acreage of Biotech Crops in US, Argentina, India,
Canada, China, Paraguay, Bolivia, Uruguay, Australia, Mexico
and Others (2009) 12
Plants Based Drugs - Innovative Agri Biotech Products 12
Consolidated Trends 12
Animal Husbandry and Veterinary Science 12
Outlook of Health and Medical Biotechnology 13
Biotech Technologies/Fields of Medical & Health Sector 14
Bioinformatics 14
Genomics 14
Pharmacogenomics 14
Proteomics 14
Biochips 15
Overview of the Biochip Industry 15
Biochip Technology 15
Tech Giants Join the Biochip Fray 15
Biologic Drugs 15
Cell and Tissue Culture 16
Market Overview 16
Proteomics and Pharmacokinetics Drive Market Growth 16
Regulations Prompt Change in Trends 16
Biotechnology Instruments 16
Market Overview 16
Innovations and Discoveries - Fuel Demand for Biotech
Instrumentation 17
Biotechnology Reagents 17
Market Overview 17
Highly Automated Instrumentation Restricts Use of Reagents 18
Molecular Biology and Protein Synthesis Reagents are
Growing Rapidly 18
2. MERGERS AND ACQUISITIONS 19
3. STRATEGIC CORPORATE DEVELOPMENTS 38
4. PRODUCT LAUNCHES & DEVELOPMENTS 51
A REGIONAL MARKET PERSPECTIVE 61
1. NORTH AMERICA 61
1a. THE UNITED STATES 61
Overview 61
Table 8: Fundings for US Biotechnology Industry in 2010 62
Demand for Biochips to Grow Strongly 62
Agricultural Biotechnology 62
Cultivation of GM Crops Rises in US 62
Biologics - Market Overview 63
Medical Biotechnology - Market Overview 63
Table 9: US Pharmaceutical Industry (1996-2010): Number of
Drugs Approved by US FDA 63
Table 10: US Pharmaceutical Industry (2010): Percentage
Breakdown of Drug Sales by Type - Generic and Prescription 63
Table 11: US Healthcare Industry: Projected Expenditure on
Healthcare as % of GDP 64
Table 12: US Pharmaceutical Industry (2010): Top Four Drug
Development Biotechnology Companies by Revenues 64
Table 13: US Pharmaceutical Industry (2010): Percentage
Share Breakdown Number of Pipeline Drugs by Indication 64
Bioinformatics 64
Proteomics 65
Biochips 65
Challenges Faced by US Biotechnology Market 65
1b. CANADA 66
Market Overview 66
Revenues and R&D Expenditures Plunge 66
Table 14: Canadian Biotechnology Industry (2010): Funds
Raised by Biotechnology Clusters 67
1c. MEXICO 68
End-Use Industries 68
Bio-Pharmaceuticals 68
Food Biotechnology 68
Environmental Biotechnology 68
2. JAPAN 69
Biotechnology Market Overview 69
Japanese Companies Expand Business Operations 69
End-Use Industries 70
Medical Biotechnology and Healthcare 70
Biosimilars 70
Food Biotechnology Industry 70
Environmental Biotechnology 70
3. EUROPE 71
Industry Overview 71
Table 15: European Biotechnology Industry (2010): Number of
Biotechnology Product Candidates by Country 72
Finance Scenario 72
Table 16: VC Fundings in US and Europe (2010): Percentage
Share Breakdown by Indication 73
Regulatory and Policy Landscape 73
Current & Future Analysis 73
Table 17: European Biotechnology Market by Country/Region -
France, Germany, Italy, UK, Spain and Rest of Europe - With
Annual Revenues in US$Million for Years 2010 through 2015 74
Table 18: European Biotechnology Market (2011 & 2015):
Percentage Breakdown of Value Sales by Country/Region 75
Table 19: Number of Public Biotechnology Companies in Europe
by Country (2010) 75
3a. DENMARK 76
3b. FRANCE 77
Overview 77
French Government Takes Active Measures to Boost Financing 77
Challenges and Outlook 77
3c. GERMANY 78
Overview 78
Government Support 78
3d. ITALY 79
Overview 79
3e. THE NETHERLANDS 80
Market Prospects 80
3f. POLAND 81
Overview 81
Market Access Regulations 81
3g. UNITED KINGDOM 82
Agricultural Biotechnology 82
Impact of Financial Crisis and Outlook 83
3h. SWEDEN 83
Overview 83
3i. SWITZERLAND 84
Overview 84
3j. SPAIN 85
4. ASIA-PACIFIC 86
Overview 86
4a. AUSTRALIA 87
Overview 87
4b. NEW ZEALAND 88
Overview 88
Biotech Companies Attract 88
Investments from Asia 88
Government Support 88
4c. CHINA 89
Pharmaceutical Segment Dominates Chinese Biotech Market 89
Table 20: Chinese Biopharmaceutical Market (2010): Funds
Raised by IPOs 90
4d. INDIA 91
Market Overview 91
Table 21: Indian Biotechnology Market (2010): Percentage
Breakdown of Value Sales by Segment - Biopharma, Bioagri,
Bioservices, Bioindustry and Bioinformatics 91
Booming Biotechnology Industry 92
Exports - A Major Market for Indian Biotech Industry 92
Bioinformatics Market to Grow Exponentially in India 92
Bio-pharma Drives Growth in Biotech Industry 92
Overview of the Biosimilars Sector 93
Personalized Medicine - An Emerging Field 93
A Growing Hub for Clinical Trials and R&D 93
M&A Scenario Remains Strong 94
Select Corporate Developments in India (2010) 94
Transformation - Creating a Platform for Future Growth in
Biotech Industry 94
Regulatory Environment in India 95
Challenges 95
4e. MALAYSIA 96
Overview of Malaysian Biotechnology Industry 96
Role of National Biotechnology Directorate (Biotek) 96
4f. SOUTH KOREA 97
Biotechnology Industry Overview 97
4g. TAIWAN 98
4h. SINGAPORE 99
Overview 99
Singapore Biotech Start-ups Face Funding Challenges 99
5. OTHER MARKETS 100
5a. ARGENTINA 100
5b. BRAZIL 101
Industry Outlook 101
Government Support Spurs Biotech Industry 101
End-Use Industries 101
Diagnostics 101
Biopharmaceuticals 101
Biotechnology and Animal Health 101
Agricultural Biotechnology 102
Environmental Biotechnology 102
Biotechnology in Food Processing 102
5c. ISRAEL 102
GLOBAL DIRECTORY
To order this report:
Biotechnology Industry: Global Biotechnology Industry
Check our Industry Analysis and Insights
CONTACT:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article